NASDAQ : MDBH

MDB Capital Holdings, LLC Class A common — News

$3.03 USD

$0 (0.0%)

Volume
207
Average Volume
4.33K
Market Capitalization
$30.57M
P/E Ratio
-1.43
Dividend Yield
0.00%
Price Target
Year High
$4.80
Year Low
$2.45
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$36.63
Source Headline
MDB Capital Holdings to Host Second Quarter 2026 Update Call on Thursday August 13, 2026 at 4:30 p.m. Eastern Time

Addison, TX, July 30, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-defining, disruptive technology companies, will host a Zoom webinar on Thursday, August 13, 2026 at 4:30 p.m. Eastern Time to provide an operational update for the quarter ended June 30, 2026, and subsequent developments. A press release detailing the updates will be issued prior to the call.

globenewswire.com - 2026-07-30 16:00:00

What Is OpenAI Actually Patenting? PatentVest Pulse Analyzes OpenAI's Patent Portfolio

New PatentVest Pulse report reveals how OpenAI's published patent portfolio maps its AI product strategy across conversational AI, AI agents, generative media, developer platforms, personalization, and infrastructure New PatentVest Pulse report reveals how OpenAI's published patent portfolio maps its AI product strategy across conversational AI, AI agents, generative media, developer platforms, personalization, and infrastructure

globenewswire.com - 2026-07-23 12:45:00

What Is OpenAI Actually Patenting? PatentVest Pulse Analyzes OpenAI's Patent Portfolio

DALLAS, Texas, July 23, 2026 (GLOBE NEWSWIRE) -- PatentVest, the first fully integrated IP intelligence, strategy, and law firm, today released its latest PatentVest Pulse, an in-depth analysis of OpenAI's published patent portfolio and intellectual property strategy. Titled "What Is OpenAI Actually Patenting?

globenewswire.com - 2026-07-23 12:45:00

PatentVest Publishes New IP Legal Insights Article Examining Why Patent Prosecution Is Ready for AI

Dallas, TX, July 02, 2026 (GLOBE NEWSWIRE) -- PatentVest today announced the publication of a new article in its IP Legal Insights section, continuing the firm's commitment to providing practical legal guidance on the technologies and legal developments reshaping intellectual property.

globenewswire.com - 2026-07-02 11:05:00

PatentVest Releases New PatentVest Pulse Report Exploring the Strategic Shift Beyond GLP-1

The new PatentVest Pulse report examines how FGF21 is emerging as the next strategic cardiometabolic layer beyond GLP-1, reshaping obesity therapeutics, pharmaceutical partnerships, and intellectual property strategy The report analyzes more than $10. 7 billion in recent acquisitions and licensing activity, highlighting how leading pharmaceutical companies are positioning themselves for the next phase of obesity innovation Dallas, TX, June 30, 2026 (GLOBE NEWSWIRE) -- Today, PatentVest, a leading provider of IP Strategy and IP Law services, announced the release of its latest PatentVest Pulse report, "The Crossover: How FGF21 Became the Cardiometabolic Layer Beneath GLP-1.

globenewswire.com - 2026-06-30 09:30:00

PatentVest Releases New PatentVest Pulse Report Exploring the Strategic Shift Beyond GLP-1

Dallas, TX, June 30, 2026 (GLOBE NEWSWIRE) -- Today, PatentVest, a leading provider of IP Strategy and IP Law services, announced the release of its latest PatentVest Pulse report, "The Crossover: How FGF21 Became the Cardiometabolic Layer Beneath GLP-1."

globenewswire.com - 2026-06-30 09:30:00

PatentVest to Present at Planet MicroCap Las Vegas on June 17

PatentVest Will Discuss Intellectual Property Strategy, Innovation Intelligence, and the Future of AI-Native IP Services PatentVest Will Discuss Intellectual Property Strategy, Innovation Intelligence, and the Future of AI-Native IP Services

globenewswire.com - 2026-06-15 12:30:00

New PatentVest Pulse Report Maps the Emerging Muscle-Preservation Category Expanding the GLP-1 Opportunity

• Analysis of 20 muscle-preservation programs highlights a rapidly emerging category designed to enhance long-term obesity treatment outcomes • PatentVest's report reveals how combination therapy IP, body-composition optimization, and strategic acquisitions may shape the next phase of obesity therapeutics Dallas, Texas, June 04, 2026 (GLOBE NEWSWIRE) -- Today, PatentVest, a leading provider of IP Strategy and IP Law services, announces the release of its latest report, "The Muscle Problem: How Myostatin Could Expand the GLP-1 Opportunity" This comprehensive study provides a strategic analysis of the emerging muscle-preservation category developing alongside obesity therapies.

globenewswire.com - 2026-06-04 13:05:00

New PatentVest Pulse Report Maps the Emerging Muscle-Preservation Category Expanding the GLP-1 Opportunity

• Analysis of 20 muscle-preservation programs highlights a rapidly emerging category designed to enhance long-term obesity treatment outcomes

globenewswire.com - 2026-06-04 13:05:00

MDB Capital to Present at Planet MicroCap Las Vegas 2026 Along with Subsidiary PatentVest and Portfolio Company Buda Juice

Addison, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC (NASDAQ: MDBH) today announced that its CEO & Co-Founder, Chris Marlett, will present live at the Planet MicroCap Las Vegas 2026 conference on Wednesday, June 17, 2026 at 2:00 p.m. ET / 11:00 a.m. PT at the Bellagio Resort & Hotel in Las Vegas, Nevada.

globenewswire.com - 2026-06-03 16:05:00

PatentVest Launches New Case Studies Section Featuring Strategic AI IP Engagement with Docana

Dallas, TX, May 19, 2026 (GLOBE NEWSWIRE) -- Today, PatentVest, a leading provider of IP Strategy and IP Law services, announced the launch of a new Case Studies section on its website, beginning with a featured engagement with Docana, an artificial intelligence company operating within a rapidly evolving LLM-related patent environment.

globenewswire.com - 2026-05-19 09:00:00

Get MDBH Insider Trade Alerts

MDBH Price Target Summary

Last Month

0 analysts

Last Quarter

0 analysts

Last Year

0 analysts

All Time

0 analysts

MDBH Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade